Concerning non-small cell lung cancer, Fu et al. reported that ALDOA can activate the EGFR/MAPK pathway to promote cyclin D1 expression, enhance proliferation and G1/G transition, and facilitate aerobic glycolysis (Fu et al., 2018). The gene discussed is ALDOA; the disease is non-small cell lung carcinoma.